Key Synthetic Bone Graft Substitutes Market Players:
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Stryker Corporation
- Zimmer Biomet Holdings
- Baxter International
- Smith+Nephew
- Johnson & Johnson
- Olympus Corporation
- NuVasive, Inc.
- Wright Medical Group
- Orthofix Medical
- DJO Global (Enovis)
- Cerapedics
- Biocomposites Ltd
- Graftys
- Xtant Medical
- Amedica Corporation
- Surgival
- Osseon LLC
- Bioventus LLC
- Osteopore International
There is a prominent visibility for the synthetic bone graft substitutes market due to the presence of key organizations with a collective aim of capturing a high market share. The market presents itself as a highly consolidated form, with Medtronic, Stryker, and Zimmer Biomet controlling 61% of global revenue. In this regard, NIH states that Stryker’s 3D-printed Tritanium grafts reduced revision rates by 30%. Similarly, in 2023, Zimmer Biomet acquired Embody, which strengthened its collagen graft portfolio, reflecting positive market adoption. Focus on affordable healthcare and collaborations with regulatory frameworks further strengthens the global market landscape.